Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 540 | 13989 | 31.7 | 72% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 179 | 52887 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 705 | 3079 | TOPOISOMERASE II//ICRF 193//DNA TOPOISOMERASE II |
| 1283 | 2641 | LB20304//AT 4140//TEMAFLOXACIN |
| 5393 | 1563 | NORFLOXACIN//FLUOROQUINOLONES//OFLOXACIN |
| 5748 | 1514 | DNA GYRASE//GYRASE//REVERSE GYRASE |
| 6274 | 1441 | GEMIFLOXACIN//GEMIFLOXACIN MESYLATE//GARENOXACIN |
| 9914 | 1044 | ANTOFLOXACIN HYDROCHLORIDE//SKELETAL TOXICITY//ANTOFLOXACIN |
| 11416 | 917 | N SUBSTITUTED PIPERAZINYL QUINOLONES//PIPERAZINYL QUINOLONES//S ENOKI 3394 |
| 13149 | 793 | INTERACTION WITH CALF THYMUS DNA//COMPETITIVE STUDIES WITH ETHIDIUM BROMIDE//NORFLOXACIN |
| 14600 | 693 | PRULIFLOXACIN//ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS//ACUTE EXACERBATION OF CHRONIC BRONCHITIS |
| 24761 | 252 | EQUIPE ACCUEIL EA 3105//ESCHERICHIA COLI WP2UVRA PKM101//DIRECC INVEST ENSENANZA |
| 35120 | 52 | RUFLOXACIN//ONCE A DAY ADMINISTRATION//RUFLOXACIN HYDROCHLORIDE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FLUOROQUINOLONES | Author keyword | 234 | 34% | 4% | 561 |
| 2 | CIPROFLOXACIN | Author keyword | 168 | 26% | 4% | 563 |
| 3 | QUINOLONES | Author keyword | 161 | 36% | 3% | 362 |
| 4 | FLUOROQUINOLONE | Author keyword | 135 | 36% | 2% | 302 |
| 5 | NORFLOXACIN | Author keyword | 133 | 43% | 2% | 236 |
| 6 | DNA GYRASE | Author keyword | 106 | 54% | 1% | 136 |
| 7 | TOPOISOMERASE II | Author keyword | 103 | 35% | 2% | 239 |
| 8 | GEMIFLOXACIN | Author keyword | 93 | 70% | 1% | 78 |
| 9 | GATIFLOXACIN | Author keyword | 83 | 45% | 1% | 137 |
| 10 | OFLOXACIN | Author keyword | 82 | 31% | 2% | 221 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FLUOROQUINOLONES | 234 | 34% | 4% | 561 | Search FLUOROQUINOLONES | Search FLUOROQUINOLONES |
| 2 | CIPROFLOXACIN | 168 | 26% | 4% | 563 | Search CIPROFLOXACIN | Search CIPROFLOXACIN |
| 3 | QUINOLONES | 161 | 36% | 3% | 362 | Search QUINOLONES | Search QUINOLONES |
| 4 | FLUOROQUINOLONE | 135 | 36% | 2% | 302 | Search FLUOROQUINOLONE | Search FLUOROQUINOLONE |
| 5 | NORFLOXACIN | 133 | 43% | 2% | 236 | Search NORFLOXACIN | Search NORFLOXACIN |
| 6 | DNA GYRASE | 106 | 54% | 1% | 136 | Search DNA+GYRASE | Search DNA+GYRASE |
| 7 | TOPOISOMERASE II | 103 | 35% | 2% | 239 | Search TOPOISOMERASE+II | Search TOPOISOMERASE+II |
| 8 | GEMIFLOXACIN | 93 | 70% | 1% | 78 | Search GEMIFLOXACIN | Search GEMIFLOXACIN |
| 9 | GATIFLOXACIN | 83 | 45% | 1% | 137 | Search GATIFLOXACIN | Search GATIFLOXACIN |
| 10 | OFLOXACIN | 82 | 31% | 2% | 221 | Search OFLOXACIN | Search OFLOXACIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | QUINOLONES | 374 | 46% | 4% | 604 |
| 2 | CIPROFLOXACIN | 364 | 24% | 9% | 1326 |
| 3 | FLUOROQUINOLONES | 338 | 35% | 6% | 791 |
| 4 | DNA GYRASE | 296 | 40% | 4% | 573 |
| 5 | GYRASE | 253 | 60% | 2% | 274 |
| 6 | QUINOLONE | 234 | 50% | 2% | 334 |
| 7 | EUKARYOTIC TOPOISOMERASE | 209 | 81% | 1% | 125 |
| 8 | TOPOISOMERASE IV | 202 | 50% | 2% | 292 |
| 9 | QUINOLONE ANTIBACTERIALS | 202 | 70% | 1% | 167 |
| 10 | NALIDIXIC ACID | 187 | 45% | 2% | 313 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| DNA topoisomerases: Structure, function, and mechanism | 2001 | 1280 | 184 | 81% |
| DNA topoisomerases | 1996 | 1684 | 496 | 79% |
| DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs | 2010 | 305 | 105 | 72% |
| Cellular roles of DNA topoisomerases: A molecular perspective | 2002 | 1137 | 111 | 50% |
| Drugging Topoisomerases: Lessons and Challenges | 2013 | 96 | 137 | 56% |
| Targeting DNA topoisomerase II in cancer chemotherapy | 2009 | 354 | 156 | 49% |
| DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS | 1989 | 1842 | 134 | 66% |
| DNA topoisomerases: harnessing and constraining energy to govern chromosome topology | 2008 | 166 | 274 | 82% |
| Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism | 2014 | 21 | 278 | 61% |
| Topoisomerase I inhibitors: camptothecins and beyond | 2006 | 648 | 140 | 35% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNIDAD GENET BACTERIANA | 12 | 54% | 0.1% | 15 |
| 2 | ENZYMOL ACIDES NUCL | 10 | 73% | 0.1% | 8 |
| 3 | G MORUZZI BIOCHEM | 7 | 56% | 0.1% | 9 |
| 4 | NEW PROD S 1 | 6 | 35% | 0.1% | 14 |
| 5 | FISICOQUIM 5 | 6 | 100% | 0.0% | 4 |
| 6 | GRP SOLID PHASE SPE OMETRY | 5 | 63% | 0.0% | 5 |
| 7 | S ENOKI 3394 | 5 | 63% | 0.0% | 5 |
| 8 | INTER ONCOL | 4 | 67% | 0.0% | 4 |
| 9 | PMS MANAGEMENT | 4 | 75% | 0.0% | 3 |
| 10 | PATHOL CLIN MICROBIOL | 4 | 33% | 0.1% | 10 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000025614 | CAMPTOTHECIN//SN 38//TOPOTECAN |
| 2 | 0.0000011591 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
| 3 | 0.0000011006 | DIFFUSE PANBRONCHIOLITIS//AZITHROMYCIN//ROXITHROMYCIN |
| 4 | 0.0000010038 | CHLORAMPHENICOL//JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS//TETRACYCLINES |
| 5 | 0.0000008476 | FEBRILE NEUTROPENIA//NEUTROPENIA//SEGMENTED FILAMENTOUS BACTERIA |
| 6 | 0.0000008265 | STREPTOCOCCUS PNEUMONIAE//COMMUNITY ACQUIRED PNEUMONIA//PNEUMOCOCCAL CONJUGATE VACCINE |
| 7 | 0.0000007073 | URINARY TRACT INFECTION//BACTERIURIA//ASYMPTOMATIC BACTERIURIA |
| 8 | 0.0000006239 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN |
| 9 | 0.0000005618 | BACTEROIDES FRAGILIS//CFIA//ANAEROBE |
| 10 | 0.0000005316 | QUINOLINES//IMINO DIELS ALDER REACTION//POVAROV REACTION |